Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 8
Submit an article Journal homepage
843
Views
15
CrossRef citations to date
0
Altmetric
Original Articles: Research

Phenotypic and functional characterization of a bortezomib-resistant multiple myeloma cell line by flow and mass cytometry

Linda B. BaughnDepartment of Laboratory Medicine and Pathology, Division of Laboratory Genetics, Mayo Clinic, Rochester, MN, USA;
,
Zohar SachsDivision of Hematology, Oncology, and Transplantation, Department of Medicine, Minneapolis, MN, USA;
,
Klara E. Noble-OrcuttDivision of Hematology, Oncology, and Transplantation, Department of Medicine, Minneapolis, MN, USA;
,
Amit MitraGenetics Cell Biology and Development, Division of Hematopathology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA;
,
Brian G. Van NessGenetics Cell Biology and Development, Division of Hematopathology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA;
&
Michael A. LindenDivision of Hematopathology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USACorrespondence[email protected]
Pages 1931-1940 | Received 21 Jul 2016, Accepted 24 Nov 2016, Published online: 16 Dec 2016

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Marie Lue Antony, Daniel Chang, Klara E. Noble-Orcutt, Anna Kay, Jeffrey L. Jensen, Hesham Mohei, Chad L. Myers, Karen Sachs & Zohar Sachs. (2023) CD69 marks a subpopulation of acute myeloid leukemia with enhanced colony forming capacity and a unique signaling activation state. Leukemia & Lymphoma 64:7, pages 1262-1274.
Read now

Articles from other publishers (14)

Mengping Chen, Jinxing Jiang & Jian Hou. (2023) Single-cell technologies in multiple myeloma: new insights into disease pathogenesis and translational implications. Biomarker Research 11:1.
Crossref
Ian D. Ferguson, Bonell Patiño-Escobar, Sami T. Tuomivaara, Yu-Hsiu T. Lin, Matthew A. Nix, Kevin K. Leung, Corynn Kasap, Emilio Ramos, Wilson Nieves Vasquez, Alexis Talbot, Martina Hale, Akul Naik, Audrey Kishishita, Priya Choudhry, Antonia Lopez-Girona, Weili Miao, Sandy W. Wong, Jeffrey L. Wolf, Thomas G. MartinIIIIII, Nina Shah, Scott Vandenberg, Sonam Prakash, Lenka Besse, Christoph Driessen, Avery D. PoseyJr.Jr., R. Dyche Mullins, Justin Eyquem, James A. Wells & Arun P. Wiita. (2022) The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance. Nature Communications 13:1.
Crossref
Morito Kurata, Marie Lue Antony, Klara E. Noble-Orcutt, Susan K. Rathe, Yoonkyu Lee, Hidehiro Furuno, Sachiko Ishibashi, Masumi Ikeda, Kouhei Yamamoto, Masanobu Kitagawa, David A. Largaespada & Zohar Sachs. (2022) Proliferation and Self-Renewal Are Differentially Sensitive to NRASG12V Oncogene Levels in an Acute Myeloid Leukemia Cell Line . Molecular Cancer Research 20:11, pages 1646-1658.
Crossref
Liping Li, Xiaofeng Li, An Shang, Yan Zhao, Lifang Jin, Meng Zhao & Weizhang Shen. (2022) Prognostic significance of CD56 antigen in newly diagnosed multiple myeloma: A real-world retrospective study. Medicine 101:40, pages e30988.
Crossref
Harish Kumar, Suman Mazumder, Sayak Chakravarti, Neeraj Sharma, Ujjal Kumar Mukherjee, Shaji Kumar, Linda B Baughn, Brian G Van Ness & Amit Kumar Mitra. (2022) secDrug: a pipeline to discover novel drug combinations to kill drug-resistant multiple myeloma cells using a greedy set cover algorithm and single-cell multi-omics. Blood Cancer Journal 12:3.
Crossref
Galina Nikolaevna Salogub, E.B. Rusanova, M.V. Gorchakova & E.A. Belyakova. (2022) The Prognostic Value of Immunophenotypic Characteristics of Plasma Cells in Newly Diagnosed Multiple Myeloma Patients Treated with First-Generation Proteasome Inhibitor Bortezomib. Clinical oncohematology 15:4, pages 377-387.
Crossref
John M. Astle & Huiya Huang. (2021) Mass Cytometry in Hematologic Malignancies: Research Highlights and Potential Clinical Applications. Frontiers in Oncology 11.
Crossref
Natasja L. de Vries, Ahmed Mahfouz, Frits Koning & Noel F. C. C. de Miranda. (2020) Unraveling the Complexity of the Cancer Microenvironment With Multidimensional Genomic and Cytometric Technologies. Frontiers in Oncology 10.
Crossref
Johannes M. Waldschmidt, Tushara Vijaykumar, Birgit Knoechel & Jens G. Lohr. (2020) Tracking myeloma tumor DNA in peripheral blood. Best Practice & Research Clinical Haematology 33:1, pages 101146.
Crossref
Taylor Harding, Linda Baughn, Shaji Kumar & Brian Van Ness. (2019) The future of myeloma precision medicine: integrating the compendium of known drug resistance mechanisms with emerging tumor profiling technologies. Leukemia 33:4, pages 863-883.
Crossref
Yannick Simoni, Melissa Hui Yen Chng, Shamin Li, Michael Fehlings & Evan W Newell. (2018) Mass cytometry: a powerful tool for dissecting the immune landscape. Current Opinion in Immunology 51, pages 187-196.
Crossref
Adam J. Lamble, Matthew Dietz, Ted Laderas, Shannon McWeeney & Evan F. Lind. (2018) Integrated functional and mass spectrometry-based flow cytometric phenotyping to describe the immune microenvironment in acute myeloid leukemia. Journal of Immunological Methods 453, pages 44-52.
Crossref
Ben Korin, Tania Dubovik & Asya Rolls. (2018) Mass cytometry analysis of immune cells in the brain. Nature Protocols 13:2, pages 377-391.
Crossref
Johannes M. Waldschmidt, Praveen Anand, Birgit Knoechel & Jens G. Lohr. (2018) Comprehensive characterization of circulating and bone marrow-derived multiple myeloma cells at minimal residual disease. Seminars in Hematology 55:1, pages 33-37.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.